Company News • Endpoint Arena

News Updates

Thu, May 14, 2026

2 updates

7:05 AM

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Presentation / Abstract • Phase 1/2EULAR oral presentation Thu, Jun 4, 2026, 9:15 AM BSTcabalettabio.com

7:00 AM

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

Presentation / AbstractASGCT poster presentation Thu, May 14, 2026, 7:00 AM EDTcabalettabio.com

Mon, May 4, 2026

1 updates

6:35 AM

Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering

cabalettabio.com

Tue, Apr 28, 2026

1 updates

8:00 AM

Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel

Presentation / Abstractcabalettabio.com

Mon, Apr 27, 2026

1 updates

5:00 PM

Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting

Presentation / Abstract • Phase 1/2cabalettabio.com

Mon, Mar 23, 2026

1 updates

7:30 AM

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Presentation / Abstract • Phase 1/2cabalettabio.com